{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:01:02Z","timestamp":1777507262735,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41440-020-0475-4","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T02:02:28Z","timestamp":1591149748000},"page":"1222-1230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparisons of skin microvascular changes in patients with primary aldosteronism and essential hypertension"],"prefix":"10.1038","volume":"43","author":[{"given":"Antonio","family":"Concistr\u00e8","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Petramala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bonvicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Gigante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Collalti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Olmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Iannucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Soldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Rosato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Letizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C.PAPY Study Investigators et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u20132300.","journal-title":"J Am Coll Cardiol"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243\u20131248.","journal-title":"J Am Coll Cardiol"},{"key":"475_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/ajh.2008.243","volume":"21","author":"B Strauch","year":"2008","unstructured":"Strauch B, Petr\u00e1k O, Zelinka T, Wichterle D, Holaj R, Kasalick\u00fd M, et al. Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens. 2008;21:1086\u201392.","journal-title":"Am J Hypertens"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1210\/jc.2006-0101","volume":"91","author":"D Rizzoni","year":"2006","unstructured":"Rizzoni D, Paiardi S, Rodella L, Porteri E, De Ciuceis C, et al. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J Clin Endocrinol Metab. 2006;91:2638\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/HJH.0000000000000464","volume":"33","author":"R Holaj","year":"2015","unstructured":"Holaj R, Rosa J, Zelinka T, \u0160trauch B, Petr\u00e1k O, Indra T, et al. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness. J Hypertens. 2015;33:874\u201382.","journal-title":"J Hypertens."},{"key":"475_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1055\/s-0035-1565124","volume":"47","author":"A Prejbisz","year":"2015","unstructured":"Prejbisz A, Warcho\u0142-Celi\u0144ska E, Lenders JW, Januszewicz A. Cardiovascular risk in primary hyperaldosteronism. Horm Metab Res. 2015;47:973\u201380.","journal-title":"Horm Metab Res"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","volume":"37","author":"S Laurent","year":"2001","unstructured":"Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236\u201341.","journal-title":"Hypertension."},{"key":"475_CR8","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/01.STR.0000065428.03209.64","volume":"34","author":"S Laurent","year":"2003","unstructured":"Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203\u201306.","journal-title":"Stroke."},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.33549\/physiolres.932344","volume":"61","author":"J Rosa","year":"2012","unstructured":"Rosa J, Soml\u00f3ov\u00e1 Z, Petr\u00e1k O, Strauch B, Indra T, Senitko M, et al. Peripheral arterial stiffness in primary aldosteronism. Physiol Res. 2012;61:461\u20138.","journal-title":"Physiol Res."},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168:80\u20135.","journal-title":"Arch Intern Med"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"475_CR12","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104. ESC Scientific Document Group","journal-title":"Eur Heart J"},{"key":"475_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1524-6175.2006.05712.x","volume":"8","author":"M Ceruti","year":"2006","unstructured":"Ceruti M, Petramala L, Cotesta D, Cerci S, Serra V, Caliumi C, et al. Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. J Clin Hypertens. 2006;8:642\u20138.","journal-title":"J Clin Hypertens"},{"key":"475_CR14","first-page":"155","volume":"27","author":"M Cutolo","year":"2000","unstructured":"Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27:155\u201360.","journal-title":"J Rheumatol."},{"key":"475_CR15","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1172\/JCI104436","volume":"40","author":"J CRABBE","year":"1961","unstructured":"CRABBE J. Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro. J Clin Investig. 1961;40:2103\u201310.","journal-title":"J Clin Investig"},{"key":"475_CR16","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1046\/j.1523-1755.1999.00674.x","volume":"56","author":"S Ebata","year":"1999","unstructured":"Ebata S, Muto S, Okada K, Nemoto J, Amemiya M, Saito T, et al. Aldosterone activates Na+\/H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int. 1999;56:1400\u201312.","journal-title":"Kidney Int."},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","volume":"66","author":"NK Hollenberg","year":"2004","unstructured":"Hollenberg NK. Aldosterone in the development and progression of renal injury. Kidney Int. 2004;66:1\u20139.","journal-title":"Kidney Int."},{"key":"475_CR18","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1097\/HJH.0000000000000284","volume":"32","author":"L Petramala","year":"2014","unstructured":"Petramala L, Pignatelli P, Carnevale R, Zinnamosca L, Marinelli C, Settevendemmie A, et al. Oxidative stress in patients affected by primary aldosteronism. J Hypertens. 2014;32:2022\u20139.","journal-title":"J Hypertens."},{"key":"475_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jash.2017.12.001","volume":"12","author":"E Gkaliagkousi","year":"2018","unstructured":"Gkaliagkousi E, Anyfanti P, Triantafyllou A, Gavriilaki E, Nikolaidou B, Lazaridis A, et al. Aldosterone as a mediator of microvascular and macrovascular damage in a population of normotensive to early-stage hypertensive individuals. J Am Soc Hypertens. 2018;12:50\u20137.","journal-title":"J Am Soc Hypertens"},{"key":"475_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11906-003-0012-2","volume":"5","author":"M Fritsch Neves","year":"2003","unstructured":"Fritsch Neves M, Schiffrin EL. Aldosterone: a risk factor for vascular disease. Curr Hypertens Rep. 2003;5:59\u201365.","journal-title":"Curr Hypertens Rep"},{"key":"475_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02622-2","volume":"7","author":"M Varano","year":"2017","unstructured":"Varano M, Iacono P, Tedeschi MM, Letizia C, Curione M, Savoriti C, et al. Comparisons of microvascular and macrovascular changes in aldosteronism-related hypertension and essential hypertension. Sci Rep. 2017;7:2666.","journal-title":"Sci Rep."},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","volume":"412","author":"VC Wu","year":"2011","unstructured":"Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, et al. Kidney impairment in primary aldosteronism. Clin Chim Acta. 2011;412:1319\u201325. TAIPAI Study Group","journal-title":"Clin Chim Acta"},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1681\/ASN.2004100878","volume":"16","author":"J Ribstein","year":"2005","unstructured":"Ribstein J, Du Cailar G, Fesler P, Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol. 2005;16:1320\u20135.","journal-title":"J Am Soc Nephrol"},{"key":"475_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41440-018-0093-6","volume":"41","author":"S Kishimoto","year":"2018","unstructured":"Kishimoto S, Matsumoto T, Oki K, Maruhashi T, Kajikawa M, Matsui S, et al. Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism. Hypertens Res. 2018;41:932\u20138.","journal-title":"Hypertens Res"},{"key":"475_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5830\/CVJA-2018-065","volume":"30","author":"LF Gafane-Matemane","year":"2019","unstructured":"Gafane-Matemane LF, van Rooyen JM, Schutte R, Schutte AE. Aldosterone and renin in relation to surrogate measures of sympathetic activity: the SABPA study. Cardiovasc J Afr. 2019;30:34\u201340.","journal-title":"Cardiovasc J Afr."},{"key":"475_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL. Vascular actions of aldosterone. J Vasc Res. 2013;50:89\u201399.","journal-title":"J Vasc Res"},{"key":"475_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2012.05.011","volume":"53","author":"N Queisser","year":"2012","unstructured":"Queisser N, Schupp N. Aldosterone, oxidative stress, and NF-\u03baB activation in hypertension-related cardiovascular and renal diseases. Free Radic Biol Med. 2012;53:314\u201327.","journal-title":"Free Radic Biol Med"},{"key":"475_CR28","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/en.2002-220956","volume":"144","author":"TY Chun","year":"2003","unstructured":"Chun TY, Bloem LJ, Pratt JH. Aldosterone inhibits inducible nitric oxide synthase in neonatal rat cardiomyocytes. Endocrinology. 2003;144:1712\u20137.","journal-title":"Endocrinology."},{"key":"475_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","volume":"17","author":"MJ Young","year":"2008","unstructured":"Young MJ. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr Opin Nephrol Hypertens. 2008;17:174\u201380.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"475_CR30","doi-asserted-by":"publisher","first-page":"F1059","DOI":"10.1152\/ajprenal.00202.2003","volume":"286","author":"I Juknevicius","year":"2004","unstructured":"Juknevicius I, Segal Y, Kren S, Lee R, Hostetter TH. Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Ren Physiol. 2004;286:F1059\u20131062.","journal-title":"Am J Physiol Ren Physiol"},{"key":"475_CR31","first-page":"597","volume":"17","author":"M Iglarz","year":"2004","unstructured":"Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system. Am J Hypertens. 2004;17:597\u2013603.","journal-title":"Am J Hypertens"},{"key":"475_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","volume":"48","author":"D Nagata","year":"2006","unstructured":"Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, et al. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension. 2006;48:165\u201371.","journal-title":"Hypertension."},{"key":"475_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41440-018-0043-3","volume":"41","author":"CLC Junqueira","year":"2018","unstructured":"Junqueira CLC, Magalh\u00e3es MEC, Brand\u00e3o AA, Ferreira E, Cyrino FZGA, Maranh\u00e3o PA. et al. Microcirculation and biomarkers in patients with resistant or mild-to-moderate hypertension: a cross-sectional study. Hypertens Res. 2018;41:515\u201323.","journal-title":"Hypertens Res"},{"key":"475_CR34","first-page":"10:360","volume":"16","author":"B Ruaro","year":"2019","unstructured":"Ruaro B, Smith V, Sulli A, Pizzorni C, Tardito S, Patan\u00e9 M, et al. Innovations in the assessment of primary and secondary Raynaud\u2019s phenomenon. Front Pharmacol. 2019;16:10:360.","journal-title":"Front Pharmacol."},{"key":"475_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mvr.2016.02.007","volume":"105","author":"B Ruaro","year":"2016","unstructured":"Ruaro B, Sulli A, Pizzorni C, Paolino S, Smith V, Cutolo M. Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients. Microvasc Res. 2016;105:119\u201324.","journal-title":"Microvasc Res."},{"key":"475_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.autrev.2017.11.036","volume":"17","author":"AL Herrick","year":"2018","unstructured":"Herrick AL, Murray A. The role of capillaroscopy and thermography in the assessment and management of Raynaud\u2019s phenomenon. Autoimmun Rev. 2018;17:465\u201372.","journal-title":"Autoimmun Rev."},{"key":"475_CR37","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/art.1780331103","volume":"33","author":"FM Wigley","year":"1990","unstructured":"Wigley FM, Wise RA, Mikdashi J, Schaefer S, Spence RJ. The post-occlusive hyperemic response in patients with systemic sclerosis. Arthr Rheum. 1990;33:1620\u20135.","journal-title":"Arthr Rheum."},{"key":"475_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0026-2862(03)00018-9","volume":"66","author":"S Clark","year":"2003","unstructured":"Clark S, Dunn G, Moore T, Jayson M, King TA, Herrick AL. Comparison of thermography and laser Doppler imaging in the assessment of Raynaud\u2019s phenomenon. Microvasc Res. 2003;66:73\u20136.","journal-title":"Microvasc Res."},{"key":"475_CR39","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/art.24645","volume":"61","author":"AK Murray","year":"2009","unstructured":"Murray AK, Moore TL, Manning JB, Taylor C, Griffiths CE, Herrick AL. Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders. Arthr Rheum. 2009;61:1103\u201311.","journal-title":"Arthr Rheum."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0475-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0475-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-0475-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:24:54Z","timestamp":1684617894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-0475-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1038\/s41440-020-0475-4","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"23 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest. The authors are responsible for the content and writing of the paper. All authors have approved the manuscript in the present form. This study was not funded. The manuscript is not under consideration for publication elsewhere. All authors give final approval of the version to be submitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}